Castle Biosciences Wins 2026 Genomics Innovation Award
FRIENDSWOOD, Texas, May 12, 2026 Castle Biosciences announced that its AdvanceAD-Tx™ gene expression profiling test received the prestigious 2026...
Molecular Diagnostics
Advertisement
Alkermes Reports Strong Phase 3 LUMRYZ Trial Data
DUBLIN, Ireland, May 12, 2026 Alkermes announced positive topline results from the pivotal REVITALYZ Phase 3 clinical trial evaluating...
Partner Therapeutics Strengthens Oncology Portfolio With BIZENGRI
LEXINGTON, Mass., May 11, 2026 Partner Therapeutics, Inc. (PTx) announced that the U.S. Food and Drug Administration (FDA) has...
Belay Diagnostics Summit Improves CNS Cancer Detection
CHICAGO, United States – May 6, 2026 Belay Diagnostics has announced new peer-reviewed clinical data demonstrating that its Belay...
Castle Biosciences Unveils TissueCypher Data at DDW 2026
FRIENDSWOOD, TEXAS, May 04, 2026 Castle Biosciences has announced the presentation of new clinical data at Digestive Disease Week...
Advertisements
CareDx Acquires Naveris to Expand Precision Oncology
BRISBANE, CALIFORNIA, April 28, 2026 CareDx Inc. has announced a definitive agreement to acquire Naveris, marking a significant expansion...
QuidelOrtho Acquires LEX to Boost Rapid PCR Diagnostics
SAN DIEGO, April 20, 2026 QuidelOrtho Corporation has completed its acquisition of LEX Diagnostics for approximately $100 million, marking...
Foundation Medicine Expands MRD Platform with SAGA Deal
BOSTON, April 16, 2026 Foundation Medicine, Inc. has announced a major expansion of its oncology diagnostics portfolio through the...
Co-Diagnostics Expands GMP Facility in Saudi Arabia
SALT LAKE CITY, April 2, 2026 Co-Diagnostics, Inc. announced that its joint venture CoMira Diagnostics has received approval to...
Veracyte Appoints Kevin Haas to Drive Diagnostic Innovation
South San Francisco, California, March 16, 2026 Veracyte, Inc. announced the appointment of Kevin Haas, Ph.D., as Chief Development...
Advertisement
